الصحة والعلوم الشرق الأوسط
New Study Shows Unexpected Health Benefit of Cranberry Juice
Lamine Yamal raises the "304" signal after goals: the meaning behind the celebration
Argentina Used 31 Dirty Tricks to Beat England in Match
U.S. Secretary of Defense Shares Photo of Tower Collapse in Chabahar
World Health Organization reveals new findings about Ebola outbreak
Source: الصحة والعلوم الشرق الأوسط
5 HrsReady to play
Ready to play
A US clinical study has shown that an experimental vaccine targeting genetic mutations associated with pancreatic cancer elicited a strong and long-lasting immune response in at-risk individuals. The results indicated that 90% of participants developed an immune response, with a significant increase in T-cell activity and immune cells remaining present for up to two years. No cases of pancreatic cancer developed among the participants during the follow-up period, and the vaccine was well tolerated with mild side effects. This study marks an initial step toward developing preventive vaccines that target genetic mutations before symptoms appear, representing a new approach in combating this type of cancer.
Notice: This Is an AI-Generated Summary
Comments (0)